Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Detractors said the study results proved that RDN ... payment for the Medtronic Symplicity Spyral renal denervation (RDN) catheter under the Medicare Hospital Outpatient Prospective Payment ...

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation for patients with hypertension, Medtronic announced. The FDA said ...

Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device.

People often take medications for hypertension, but they can stop working over time, said Jason Fontana, Medtronic vice president and general manager of renal denervation. Patients might stop ...

This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the Symplicity™ Spyral renal denervation (RDN) system ...

Medtronic said Monday the Centers for Medicare and Medicaid Services opened a national coverage analysis for renal denervation procedures in patients with high blood pressure. The policy ...